Pfizer Seeks FDA Emergency Authorization for 3rd Booster Shot to Strengthen Protection Against Delta Variant

Pfizer will seek emergency use authorization from the FDA for a third booster shot of its Covid-19 vaccine, specifically intended to increase the immune response to the delta variant of the virus and to combat a drop-off in antibodies approximately six months after inoculation. The highly contagious delta variant has spread rapidly and currently accounts for most new Covid-19 infections in the U.S.

RELATED: Here comes the Pfizer booster for the Delta variant

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s